SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001600132-18-000057
Filing Date
2018-05-10
Accepted
2018-05-10 08:42:31
Documents
54
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q blph03311810q.htm 10-Q 650907
2 EXHIBIT 31.1 blph03311810qexhibit311.htm EX-31.1 9899
3 EXHIBIT 31.2 blph03311810qexhibit312.htm EX-31.2 9888
4 EXHIBIT 32 blph03311810qexhibit32.htm EX-32 10870
  Complete submission text file 0001600132-18-000057.txt   3658328

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT blph-20180331.xml EX-101.INS 667142
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blph-20180331.xsd EX-101.SCH 33359
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blph-20180331_cal.xml EX-101.CAL 45860
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blph-20180331_def.xml EX-101.DEF 140499
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blph-20180331_lab.xml EX-101.LAB 458143
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blph-20180331_pre.xml EX-101.PRE 252025
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36845 | Film No.: 18820673
SIC: 2834 Pharmaceutical Preparations